|
ECT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.216000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.414200E-01 |
| Normal-vs-Stage2 |
8.422600E-01 |
| Normal-vs-Stage3 |
8.714200E-01 |
| Normal-vs-Stage4 |
9.976400E-03 |
| Stage1-vs-Stage2 |
9.176400E-01 |
| Stage1-vs-Stage3 |
8.408600E-01 |
| Stage1-vs-Stage4 |
2.639600E-03 |
| Stage2-vs-Stage3 |
9.513000E-01 |
| Stage2-vs-Stage4 |
6.518500E-03 |
| Stage3-vs-Stage4 |
4.915900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.950800E-01 |
| Normal-vs-AfricanAmerican |
5.959600E-01 |
| Normal-vs-Asian |
7.793800E-01 |
| Caucasian-vs-AfricanAmerican |
7.311600E-01 |
| Caucasian-vs-Asian |
9.130600E-01 |
| AfricanAmerican-vs-Asian |
9.172400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.850800E-01 |
| Normal-vs-Female |
9.565800E-01 |
| Male-vs-Female |
4.402000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.386620E-01 |
| Normal-vs-Age(41-60Yrs) |
6.696000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.449000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.221600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.729840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.494570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.735800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.404000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.063800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.336600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.756420E-01 |
| Normal-vs-Grade 2 |
6.098200E-01 |
| Normal-vs-Grade 3 |
8.911000E-01 |
| Normal-vs-Grade 4 |
2.053600E-02 |
| Grade 1-vs-Grade 2 |
2.283200E-01 |
| Grade 1-vs-Grade 3 |
8.963900E-02 |
| Grade 1-vs-Grade 4 |
1.542240E-03 |
| Grade 2-vs-Grade 3 |
4.023600E-01 |
| Grade 2-vs-Grade 4 |
5.521000E-03 |
| Grade 3-vs-Grade 4 |
1.850350E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.306500E-02 |
| Normal-vs-ccB subtype |
5.656400E-02 |
| ccA subtype-vs-ccB subtype |
1.50746999999507E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.468600E-01 |
| Normal-vs-N1 |
1.967890E-02 |
| N0-vs-N1 |
2.117700E-02 |
|
|
